Physician profile

Christopher G Genobaga

Obstetrics & Gynecology · Yuba City, CA

NPI 1902826894

$4,906.05

in general payments reported to CMS, 2019-2025

4 companies · none reported in 2025

See the full distribution for Obstetrics & Gynecology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Education$4,500.00
Travel and Lodging$264.13
Food and Beverage$123.80

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $4,792.28 2023 Davinci Xi, Da Vinci Surgical System
Ethicon US, LLC $78.04 2023-2024 Harmonic, Surgicel Nu-Knit, Vistaseal
Merck Sharp & Dohme LLC $18.12 2020
Medical Device Business Services, INC. $17.61 2024 Vistaseal

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Christopher G Genobaga

$4,906.05

in general payments reported 2019-2025

Years
2020-2024
Top company
Intuitive Surgical, INC.

https://glasscript.com/doctor/85682/christopher-g-genobaga

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.